All In Biotech

Drug Trial Radar · NCT07546214

A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.

A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study, Comparing Tapinarof Cream, 1% (Sun Pharma Canada, Inc.) and Vtama® (Tapinarof) Cream, 1% in the Treatment of Plaque Psoriasis.

Last checked: Nov 20, 2026Latest source record: Apr 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 575 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

575

Actual

Start

Oct 13, 2025

Primary completion

Mar 18, 2026

Study completion Mar 18, 2026

Sponsor

Sponsor type
Industry
First posted
Apr 22, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To demonstrate therapeutic equivalence and safety of Tapinarof Cream, 1% (Sun pharma Canada, Inc.) and Vtama® (Tapinarof) Cream, 1% in the treatment of plaque psoriasis.

Conditions

  • Plaque Psoriasis

Interventions

  • Tapinarof Cream, 1%Drug

    The investigational product will be self-applied topically to the affected areas of the face once daily in the evening for 84 consecutive days.

  • Vtama® (Tapinarof) Cream, 1%Drug

    The investigational product will be self-applied topically to the affected areas of the face once daily in the evening for 84 consecutive days.

  • Placebo ControlDrug

    The investigational product will be self-applied topically to the affected areas of the face once daily in the evening for 84 consecutive days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Demonstration in Therapeutic Equivalence & Safety of the Investigational ProductTime frame: Baseline to Week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sun Pharmaceutical Industries, Inc.

    Hawthorne, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.